Correlation Between Reviva Pharmaceuticals and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Roivant Sciences, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Roivant Sciences.
Diversification Opportunities for Reviva Pharmaceuticals and Roivant Sciences
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Reviva and Roivant is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Roivant Sciences go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Roivant Sciences
Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 8.93 times more return on investment than Roivant Sciences. However, Reviva Pharmaceuticals is 8.93 times more volatile than Roivant Sciences. It trades about 0.29 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.23 per unit of risk. If you would invest 10.00 in Reviva Pharmaceuticals Holdings on September 1, 2024 and sell it today you would earn a total of 12.00 from holding Reviva Pharmaceuticals Holdings or generate 120.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Roivant Sciences
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Roivant Sciences |
Reviva Pharmaceuticals and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Roivant Sciences
The main advantage of trading using opposite Reviva Pharmaceuticals and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
| Roivant Sciences vs. Krystal Biotech | Roivant Sciences vs. Akero Therapeutics | Roivant Sciences vs. Apellis Pharmaceuticals | Roivant Sciences vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |